FDA-Inspected Site

St Agnes Healthcare Blood Bank

5 FDA inspections are on record for St Agnes Healthcare Blood Bank in Baltimore, United States.

483· Form 483 issued

Baltimore, United States · Last updated July 11, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2011-02-04.

At a glance

Inspections

5

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Feb 2011Not recorded483View 483 →
17 Jul 2009Not recorded483View 483 →
24 Aug 2007Not recordedClean
21 May 2003Not recordedClean
28 Mar 2001Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Feb 2011
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Tamika E Allen

4 Feb 2011
21 CFR 606.100(c)

Thorough investigations

Cited by Tamika E Allen

4 Feb 2011
21 CFR 606.170(a)

Adverse Reaction- Reports of Investigations

Cited by Tamika E Allen

17 Jul 2009
21 CFR 600.80(c)(2)(ii)

Reporting Requirement - Periodic adv. exp. report content

Cited by Joseph W Matthews

17 Jul 2009
21 CFR 606.100(b)

Written SOPs available for use by personnel

Cited by Joseph W Matthews

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 606.100(b)Cited across public-safe Form 483 observations2x
21 CFR 600.80(c)(2)(ii)Cited across public-safe Form 483 observations1x
21 CFR 606.100(c)Cited across public-safe Form 483 observations1x
21 CFR 606.170(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind St Agnes Healthcare Blood Bank's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat